ESPOSITO, Carla
 Distribuzione geografica
Continente #
NA - Nord America 7.247
AS - Asia 4.896
EU - Europa 2.221
SA - Sud America 374
AF - Africa 54
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.800
Nazione #
US - Stati Uniti d'America 7.130
HK - Hong Kong 2.208
SG - Singapore 1.124
CN - Cina 754
IT - Italia 524
UA - Ucraina 497
VN - Vietnam 393
BR - Brasile 288
DE - Germania 274
RU - Federazione Russa 225
FI - Finlandia 173
FR - Francia 145
IE - Irlanda 140
TR - Turchia 88
KR - Corea 78
SE - Svezia 78
GB - Regno Unito 67
IN - India 65
MX - Messico 55
CA - Canada 46
BD - Bangladesh 30
AR - Argentina 28
IQ - Iraq 25
JP - Giappone 25
ZA - Sudafrica 22
PL - Polonia 19
CO - Colombia 17
ES - Italia 16
CZ - Repubblica Ceca 13
ID - Indonesia 13
PK - Pakistan 13
VE - Venezuela 13
PH - Filippine 11
SA - Arabia Saudita 11
CL - Cile 10
JO - Giordania 10
UZ - Uzbekistan 10
MA - Marocco 9
IL - Israele 7
NL - Olanda 7
AT - Austria 6
MY - Malesia 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
KE - Kenya 5
LT - Lituania 5
RS - Serbia 5
AL - Albania 4
AU - Australia 4
BO - Bolivia 4
PE - Perù 4
BY - Bielorussia 3
ET - Etiopia 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
PY - Paraguay 3
RO - Romania 3
TT - Trinidad e Tobago 3
AO - Angola 2
BG - Bulgaria 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GR - Grecia 2
HN - Honduras 2
KG - Kirghizistan 2
MN - Mongolia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
TH - Thailandia 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
DJ - Gibuti 1
DK - Danimarca 1
EU - Europa 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PT - Portogallo 1
RE - Reunion 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 14.793
Città #
Hong Kong 2.199
Ann Arbor 1.338
Wilmington 691
Chandler 619
Jacksonville 596
Singapore 574
Dallas 512
San Jose 487
Princeton 393
Ashburn 327
Houston 265
Dong Ket 210
Woodbridge 209
Beijing 148
Munich 139
Dublin 137
Council Bluffs 115
Boardman 111
Nanjing 110
Dearborn 107
The Dalles 99
Andover 97
Lauterbourg 93
Pellezzano 76
Ho Chi Minh City 70
Salerno 65
Izmir 62
Helsinki 58
Los Angeles 54
Mestre 49
Moscow 49
Fairfield 41
Hanoi 40
Redwood City 37
São Paulo 36
Nanchang 35
Hebei 33
Shenyang 33
New York 30
Changsha 27
Orem 25
Tokyo 25
Montreal 21
Tianjin 21
Jiaxing 20
Pune 20
Warsaw 19
Santa Clara 17
Chennai 16
London 16
Napoli 16
Sant'agata De' Goti 16
Washington 15
Brooklyn 14
Cuauhtémoc 14
Stockholm 14
Agropoli 13
Istanbul 13
Johannesburg 13
Brno 12
Manchester 12
Norwalk 12
Phoenix 12
Turku 12
Belo Horizonte 11
Cava 11
Chicago 11
Düsseldorf 11
Frankfurt am Main 11
Ottawa 11
San Diego 11
Seattle 11
Guangzhou 10
Medellín 10
Tashkent 10
Amman 9
Da Nang 9
Lessolo 9
Poplar 9
Bologna 8
Boston 8
Haiphong 8
Naples 8
Potenza 8
Rio de Janeiro 8
Spinea 8
Atlanta 7
Baghdad 7
Bari 7
Caserta 7
Denver 7
Jinan 7
Ankara 6
Kunming 6
Lahore 6
Marsico Nuovo 6
Mexico City 6
Rome 6
Shanghai 6
Toronto 6
Totale 11.059
Nome #
Searching for the protein targets of 4-nonylphenol using a computational approach 712
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells 645
A preliminary study on nonylphenol toxicity in human intestinal epithelial cells 564
The surfactant 4-nonylphenol is cytotoxic for cells of the human gastrointestinal tract. 339
Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases. 287
Searching for the protein targets of 4-nonylphenol using a computational approach 261
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. 240
Analysis of transglutaminase protein substrates by functional proteomics. 226
4-Nonylphenol reduces cell viability and induces apoptosis and ER-stress in a human epithelial intestinal cell line 199
An acetic acid-based extraction method to obtain high quality collagen from archeological bone remains 196
Celiac anti‑type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects 192
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca(2+) homeostasis 191
Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease 182
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 181
Antibodies against type 2 transglutaminase modulate actin rearrangements and cell cycle in several cell lines 178
Application of a computational approach to identify protein targets for 4-nonylphenol 177
The toxic alpha-gliadin peptide 31-43 enters cells without a surface membrane receptor 165
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics 162
Autoantibodies to tissue transglutaminase can induce ER (endoplasmic reticulum) stress response in Caco-2 cells 161
A-gliadin peptide 31-43 induces NF-κB and tissue transglutaminase activation in an intestinal epithelial cell line 161
Celiac autoantibodies to tissue transglutaminase modulate alpha-gliadin peptide uptake by epithelial cells 159
Anti-Tissue Transglutaminase Antibodies from Coeliac Patients Inhibit Transglutaminase Activity both in Vitro and in Situ 155
Enzymatic Strategies to Detoxify Gluten:Implications for Celiac Disease 155
ANTI-TISSUE TRANSGLUTAMINASE ANTIBODIES ACTIVATE CYTOSOLIC TISSUE TRANSGLUTAMINASE BY MOBILIZING CALCIUM IONS FROM INTRACELLULAR STORES 155
THE A-GLIADIN PEPTIDE 31-43 INDUCES NF-kB ACTIVATION AND MODULATE TYPE 2 TRANSGLUTAMINASE ACTIVITY IN AN INTESTINAL EPITHELIAL CELL LINE 155
Interaction of 'toxic' and 'immunogenic' A-gliadin peptides with a membrane-mimetic environment 154
Identification of differential phosphorylated proteins in Caco-2 cells treated with anti-tissue transglutaminase antibodies 152
Synthesis of peptidocalix[4]arene diversomers as transglutaminase inhibitors by protein surface recognition 152
Gliadin Peptides Induce Tissue Transglutaminase Activation and ER-Stress through Ca(2+) Mobilization in Caco-2 Cells. 149
Chronic Exposure to Cadmium Disrupts the Adrenal Gland Activity of the Newt Triturus carnifex (Amphibia, Urodela) 148
Tissue transglutaminase in celiac disease: role of autoantibodies. 145
A-GLIADIN PEPTIDES INDUCE TISSUE TRANSGLUTAMINASE ACTIVATION THROUGH CA2+ MOBILIZATION IN CACO-2 CELLS 143
Biochemical characterization of recombinant rat prostate transglutaminase expressed into MDCK cells 142
Anti-tissue transglutaminase antibodies have biological effects on cultured intestinal biopsies from celiac patients 141
Mammalian Transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance. 138
Caratterizzazione della transglutaminasi da prostata di ratto espressa in cellule MDCK 137
Subcellular distribution of type 2 transglutaminase is constitutively different in skin derived-fibroblasts from celiac disease patients and from healthy controls 132
Constitutive differential features of type 2 transglutaminase in cells derived from celiac patients and from healthy subjects 131
Serum IgA and IgG and intestinal monoclonal anti-tissue transglutaminase antibodies from coeliac patients inhibit the catalytic activity both in vitro and in situ. 130
Internalization of alpha gliadin peptide 31-43 by Caco-2 cells does not require a surface receptor. 128
N-terminus end of rat prostate transglutaminase is responsible for its catalytic activity and GTP binding 128
Expression and enzymatic activity of small intestinal tissue transglutaminase in coeliac disease 126
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies. 125
Celiac anti-tissue transglutaminase antibodies derange alpha gliadin peptide 31-43 uptake by epithelial cells. 125
Histological changes, apoptosis and metallothionein levels in Triturus carnifex (Amphibia, Urodela) exposed to environmental cadmium concentrations 125
Type 2 transglutaminase contributes to define a cellular phenotype typical of celiac cells. 124
New therapeutic strategies for coeliac disease: tissue transglutaminase as a target 124
Celiac anti-tissue transglutaminase autoantibodies interfere with the ability of alpha-gliadin peptide 31-43 to drive intestinal epithelial cells into S-phase. 122
Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line: implications for coeliac disease. 119
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types 119
Transglutaminase 2 in celiac diasease: Minireview article 115
Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate deydrogenase and polyglutamine repeat. 115
Expression and Enzymatic Activity of Small Intestinal Tissue Transglutaminase in Coeliac Disease 112
Transglutaminase surface recognition by peptidocalix[4]arene diversomers. 112
The monoclonal anti-tissue transglutaminase antibody CUB 7402 reduces the alpha-gliadin peptides uptake by Caco-2 cells 112
Interplay between type 2 transglutaminase (Tg2), gliadin peptide 31-43 and anti-tg2 antibodies in celiac disease 111
Seminal Vesicle Protein IV and Its Derived Active Peptides: A Possible Physiological Role in Seminal Clotting. 110
Riconoscimento di superficie delle transglutamminasi mediante diversomeri peptidocalix[4]arenici 109
Tissue Transglutaminase and Coeliac Disease. 108
GTPase and transglutaminase are associated in the secretion of rat anterior prostate. 107
Tissue transglutaminase modulators regulate actin rearrangements and cell cycle in several cell types 107
Non celiac patients’ anti-tissue transglutaminase antibodies: immunological and functional characterization. 107
Studi di specificità di isoforme dell'enzima transglutaminasi per modificare proteine del latte 106
Characterisation of rat coagulating gland transglutaminase expressed in heterologous cell systems 106
Tissue transglutaminase is implicated in the antiproliferative and proapoptotic effect induced by the histone deacetylase inhibitor 105
Identification of acyl-acceptor and acyl-donor substrates for transglutaminase in CaCo-2 intestinal cell line: implications for coeliac disease 105
The Pituitary-adrenal gland Activity of Triturus carnifex (Amphibia, Urodela) exposed to Environmental Cadmium Concentrations 103
Serum immunoglobulin A and G and monoclonal antibodies anti tissue-transglutaminase from coeliac patients inhibit the catalytic activity both in vitro and in situ. 101
Studio del riconoscimento tra transglutaminasi di tipo 2 e auto-anticorpi anti-transglutaminasi caratteristici della malattia celiaca 101
Transglutaminase surface recognition by peptidocalix[4]arene diversomers 100
Effects of Methyl Bromide on activity of blood coagulation enzymes 100
Implication of cell-surface transglutaminase in gliadin peptides uptake by Caco-2 cells 99
null 98
Influenza delle modifiche post-traduzionali sulle proprietà biologiche della TGasi presente nel secreto della ghiandola coagulatoria 97
Transglutaminase-mediated amine incorporation into substance P protects the peptide against proteolysis in vitro. 94
Interaction of “toxic” and “immunogenic” A-gliadin peptides with a membrane-like environment in vitro. 94
The mechanism of cytotoxicity of 4-nonylphenol in a human hepatic cell line involves ER-stress, apoptosis, and mitochondrial dysfunction 94
Studies on transglutaminase type IV in relation to proteins occuring in rat coagulating gland secretion 93
Transglutaminase-synthesized spermine derivative of substance P recognizes rat portal vein neurokinin-3 receptors. 92
Role of type 2 transglutaminase autoantibodies in phatogenesis of celiac disease 91
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types. 88
Do tissue transglutaminase antibodies contribute to the intestinal lesion in celiac disease? 88
Transglutaminase-synthesized analogs of substance P is a selective tool for neurokinin-2 receptors. 87
Overlapping between fluorescence modifications and activation of prostate transglutaminase induced by sodium dodecylsulphate. 87
Rat coagulating gland secretion contains a kinesin heavy chain-like protein acting as type IV transglutaminase substrate 87
Substance P and its transglutaminase-synthesized spermine derivative elicit yawning behavior via nitric oxide in rats. 86
Identification of tissue transglutaminase-reactive lysine residues in glyceraldheide-3-phosphate dehydrogenase 85
Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells 85
Desmoplakin acts as transglutaminase substrate in vitro. 85
Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates the VIP/PACAP receptor activity. 84
Expression and enzymatic activity of transglutaminase in the normal and coeliac small intestinal mucosa 84
Espressione e attività enzimatica della transglutaminasi tissutale nella mucosa intestinale di pazienti celiaci 84
Enzymatic synthesis of vasoactive intestinal peptide analogs by transglutaminase. 81
Protein SV-IV promotes nitric oxide production not associated with apoptosis in murine macrophages. 80
Structural characterisation of transglutaminase-catalysed protein aggregates correlated to neurodegenerative disorders. 78
Implication of tissue transglutaminase and desmoplakin in cell adhesion mechanism in human epidermis 77
IgA e IgG sieriche e anticorpi monoclonali intestinali anti-transglutaminasi tissutale ottenuti da pazienti celiaci inibiscono l'attività catalitica sia in vitro che in situ 77
Identification of tissue transglutaminase protein substrates in Caco-2 cells 77
Rat prostate transglutaminase: biochemical properties of recombinant forms expressed into COS-1 cells 75
null 71
Totale 14.307
Categoria #
all - tutte 43.575
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.575


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021350 0 0 0 0 0 0 0 0 0 13 115 222
2021/2022769 0 0 4 2 40 13 1 25 114 87 121 362
2022/20231.343 134 103 31 176 186 260 0 166 196 0 64 27
2023/2024465 48 68 33 21 38 81 23 31 0 26 19 77
2024/20251.308 62 27 54 88 58 147 268 146 183 33 112 130
2025/20265.820 540 980 1.501 330 592 272 690 135 303 477 0 0
Totale 15.012